Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil as Adjuvant in Supraclavicular Block
NCT05183997Unknown
- Sponsor
- Assiut University
- Start
- Jan 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
01
Overview
Randomised trial of verapamil in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: duration of postoperative analgesia at 24 hours. Status: unknown.
02
Drugs
verapamil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05183997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05183997.